KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Equity Ratio (2016 - 2026)

Edwards Lifesciences has reported Equity Ratio over the past 17 years, most recently at 0.75 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 2.08% year-over-year to 0.75; the TTM value through Dec 2025 reached 0.75, down 2.08%, while the annual FY2025 figure was 0.75, 2.08% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.75 at Edwards Lifesciences, down from 0.77 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.79 in Q2 2025 and troughed at 0.65 in Q1 2021.
  • A 5-year average of 0.72 and a median of 0.72 in 2023 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: increased 12.11% in 2021 and later dropped 2.08% in 2025.
  • Year by year, Equity Ratio stood at 0.69 in 2021, then rose by 2.02% to 0.7 in 2022, then rose by 2.49% to 0.72 in 2023, then increased by 7.41% to 0.77 in 2024, then decreased by 2.08% to 0.75 in 2025.
  • Business Quant data shows Equity Ratio for EW at 0.75 in Q4 2025, 0.77 in Q3 2025, and 0.79 in Q2 2025.